ARTHROPLASTY
Thrombin-based topical haemostatic agent effective for TKR revision surgery
This report has been verified
by one or more authors of the
original publication.
Knee Surg Sports Traumatol Arthrosc. 2015 Nov;23(11):3337-42
48 patients undergoing total knee replacement (TKR) revision surgery were randomly assigned to either receive or not receive a thrombin-based topical haemostatic agent (Floseal haemostatic matrix) for the management of postoperative blood loss. The purpose of this study was to compare the effect of Floseal on blood loss and the need for blood transfusion to a control group over the first 7 postoperative days. The results of this study found that the use of Floseal significantly reduced the need for blood transfusion compared to the control group while having no statistically significant effect on intraoperative blood loss, adverse events or haemoglobin and hematocrit levels.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
